Abstract
Systemic diseases associated with inflammatory and necrotizing lesions of blood vessels, ranging from muscular arteries to glomerular capillaries to dermal venules, produce major diagnostic as well as therapeutic challenges to the clinician. Few medical conditions present as diversely both in regard to renal and extra-renal manifestations. Kussmaul and Maier in 1866 originally described a young patient with Bright’s disease and progressive muscular weakness who at autopsy exhibited nodular swelling of arteries, a condition they termed, periarteritis nodosa (1). It subsequently became evident that classical periarteritis nodosa was relatively rare, but the related name, polyarteritis nodosa, became widely accepted to describe a wide variety of vasculitic diseases. Currently, the synonomous term, systemic necrotizing vasculitis, is generally preferred since it can be more appropriately applied to vasculitic diseases with and without nodular vascular lesions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kussmaul A, Maier K: Uber eine bischer nicht beschreibene eigenthumliche Arterienerkrankung (Periarteritis nodosa), Die mit Morbus Brightii und rapid forschreitender allgemeiner Muskellahmung einhergeht. Dtsch Arch Klin Med 1: 484 – 517, 1866.
Zeek PM: Periarteritis nodosa and other forms of necrotizing angiitis. N Engl J Med 248: 764 – 772, 1953.
Cupps TR, Fauci AS: The vasculitides. W.B. Saunders Co, Philadelphia, 1981.
Fauci AS, Haynes BF, Katz P: The spectrum of vasculitis. Clinical, pathologic, immuilologic and therapeutic considerations. Ann Intern Med 89: 660 – 676, 1978.
Fan PT, Davis JA, Somer T, Kaplan L, Bluestone R: A clinical approach to systemic vasculitis. Semin Arthritis Rheum 9: 248 – 304, 1980.
Alarcon-Sepvia D: The necrotizing vasculitides. A new pathogenetic classification. Med Clin N Am 61: 241 – 260, 1977.
Balow JE. Vasculitic diseases. Clin Exp Dial Apheresis 5: 47 – 63, 1981.
Antonovych TT, Mostofi FH: Atlas of Kidney Biopsies. Armed Forces Institute of Pathology, Washington DC, 1980.
Travers RL, Allison DJ, Brettle RP, Hughes GRV: Polyarteritis nodosa: A clinical and angiographic analysis of 17 cases. Semin Arthritis Rheum 8: 184 – 199, 1979.
Sack M, Cassidy JT, Bole GG: Prognostic factors in polyarteritis. J Rheumatol 2: 411 – 420, 1975.
Leib ES, Restivo C, Paulus HE: Immunosuppressive and corticosteroid therapy of polyarteritis nodosa. Am J Med 67: 941 – 947, 1979.
Cohen RD, Conn DL, Ilstrup DM: Clinical features, prognosis and response to treatment in polyarteritis. Mayo Clin Proc 55: 146 – 155, 1980.
Frohnert PP, Sheps SG: Long-term follow-up study of periarteritis nodosa. Am J Med 43: 8 – 14, 1967.
Pirofsky B, Bardana EJ: Immunosuppressive therapy in rheumatic disease. Med Clin N Am 61: 419 – 437, 1977.
Fauci AS, Katz P, Haynes BF, Wolff SM: Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med 301: 235 – 238, 1979.
Elkon KB, Hughes GRV, Pussell BA: Treatment of vasculitis with cyclophosphamide (letter). N Engl J Med 301: 1122 – 1123, 1979.
Fauci AS, Doppman JL, Wolff SM: Cyclophosphamide- induced remissions in advanced polyarteritis nodosa. Am J Med 64: 890 – 894, 1978.
Lockshin MD: Treatment of vasculitis with cyclophosphamide (letter). N Engl J Med 301: 1123, 1979.
Lockwood CM, Pussell B, Wilson CB, Peters DK: Plasma exchange in nephritis. Adv Nephrol 8: 383 – 418.
Chalopin JM, Rifle G, Turc JM, Cortet P, Severac M: Immunological findings during successful treatment of HBsAg–associated polyarteritis nodosa by plasmapheresis alone. Brit Med J 1:308, 1980,
Lockwood CM, Worlledge S, Nicholas A, Cotton C, Peters DK: Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med 300: 524 – 530, 1979.
Wing EJ, Bruns FJ, Fraley DS, Segel DP, Adler S: Infectious complications with plasmapheresis in rapidly progressive glomerulonephritis. JAMA 244: 2423 – 2426, 1980.
Fauci AS, Wolff SM: Wegener’s granulomatosis: studies in eighteen patients and review of the literature. Medicine 52: 535 – 561, 1973.
Wolff SM, Fauci AS, Horn RG, Dale DC: Wegener’s granulomatosis. Ann Intern Med 81: 513 – 525, 1974.
Balow JE: Wegener’s granulomatosis: response of progressive glomerulonephritis to immunosuppressive therapy. In: Schreiner, Winchester, Mattem, Mendelson (eds) Controversies in Nephrology, vol 1. Georgetown University Press, Washington DC, 1980, pp 243 – 247.
Balow JE, Antonovych T, Fauci AS, Wilson CB: The nephritis of Wegener’s granulomatosis (abstract). Kidney Int 14: 706, 1978.
Appel GB, Gee B, Kashgarian M, Hayslett JP: Wegener’s granulomatosis - clinical-pathological correlations and long-term course. Am J Kidney Dis 1: 27 – 37, 1981.
Walton EW: Giant-cell granuloma of the respiratory tract (Wegener’s granulomatosis). Brit Med J 2: 265 – 270, 1968.
Hollander D, Manning RT: The use of alkylating agents in the treatment of Wegener’s granulomatosis. Ann Intern Med 67: 393 – 398, 1967.
Reza MJ, Domfield L, Goldberg LS, Bluestone P, Pearson CM: Wegener’s granulomatosis. Long-term follow-up of patients treated with cyclophosphamide. Arthritis Rheum 18: 501 - 506, 1975.
Van der Woude FJ, Arisz L, Meijer S, Donker AJM, Hoedemaeker PJ, van Overbeek JJM: Wegener’s granulomatosis. A clinicopathological study in twelve patients. Neth J Med 21: 205 – 220, 1978.
Norton WL, Suki W, Strunk S: Combined corticosteroid and azathioprine therapy in two patients with Wegener’s granulomatosis. Arch Intern Med 121: 554 – 560, 1968.
Joyce RA, Chervenick PA: Corticosteroid effect on granulopoiesis in mice after cyclophosphamide. J Clin Invest 60: 277 – 283, 1977.
Fauci AS, Dale DC, Balow JE: Glucocorticosteroid therapy: Mechanisms of action and clinical considerations. Ann Intern Med 84: 304 – 315, 1976.
Aldo MA, Benson MD, Comerford FR, Cohen AS: Treatment of Wegener’s granulomatosis with immunosuppressive agents. Arch Intern Med 126: 298 – 305, 1970.
Kuross S, Davin T, Kjellstrand CM: Wegener’s granulomatosis with severe renal failure: clinical course and resuhs of dialysis and transplantation. Clin Nephrol 16: 172 – 180, 1981.
Fauci AS, Balow JE, Brown R, Chazan J, Steinman T, Sahyoun AI, Monaco AP: Renal transplantation in Wegener’s granulomatosis: Successful alternative in renal failure. Am J Med 60: 437 – 440, 1976.
Van Ypersele de Strihou C, Pirson Y, Vanderbroucke JM, Alexandre GP: Haemodialysis and transplantation in Wegener’s granulomatosis. Brit Med J 2: 93 – 94, 1979.
Steinman TI, Jaffe BF, Monaco AP, Wolff SM, Fauci AS: Recurrence of Wegener’s granulomatosis after kidney transplantation. Successful re-induction of remission with cyclophosphamide. Am J Med 68: 458 – 460, 1980.
Cameron JS: The nephritis of Schönlein-Henoch purpura; current problems. In: Kincaid-Smith P, d’Apice AJF, Atkins RC (eds) Progress in glomerulonephritis. John Wiley, New York, 1979, p283.
Crumb CK: Renal involvement in Schönlein-Henoch syndrome. In: Suki WN (ed) The Kidney in Systemic Disease. John Wiley, New York, 1976, p 43.
Levy M, Broyer M, Arsan A, Levy-Bentolila D, Habib R: Anaphylactoid purpura nephritis in childhood: Natural history and immunopathology. Adv Nephrol 6: 183 - 228, 1976.
Meadow SR, Glasgow EF, White RHR, Moncrieff MW, Cameron JS, Ogg CS: Schönlein-Henoch nephritis. Q J Med 41: 241 – 258, 1972.
Kauffmann RH, Herrmann WA, Meyer CJLM, Daha MR, Van Es LA: Circulating IgA-immune complexes in Henoch-Schönlein purpura. A longitudinal study of their relationships to disease activity and vascular deposition of IgA. Am J Med 69: 859 – 866, 1980.
Counahan R, Winterbom MH, White RHR, Heaton JM, Meadow SR, Bluett NH, Swetschin H, Cameron JS, Chantler C: Prognosis of Henoch-Schönlein nephritis in children. Brit Med J 2: 11 – 14, 1977.
Bar-on H, Rosenmann E: Schoenlein-Henoch syndrome in adults: A clinical and histological study of renal involvement. Israel J Med Sci 8: 1702 – 1715, 1972.
Koskimies O, Mir S, Rapóla J, Vilska J: Henoch-Schönlein nephritis: Long term prognosis of unselected patients. Arch Dis Child 56: 482 – 484, 1981.
Hurley RM, Drummond KN: Anaphylactoid purpura nephritis: Clinicopathological correlations. J Pediatr 81: 904 – 911, 1972.
White RHR, Cameron JS, Trounce JR: Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome. Brit Med J 2: 853 – 860, 1966.
Michael AF, Vernier RL, Drummond KN, Levitt J, Herd- man R, Fish AJ, Good RA: Immunosuppressive therapy of chronic renal disease. N Engl J Med 276: 817 – 828, 1967.
MRC Working Party: Controlled trial of azathioprine and prednisone in chronic renal disease. Brit Med J 2: 239 – 241, 1971.
Pillastre JP, Morel-Maroger L, Richet G: Schönlein-Henoch purpura in adults. Lancet 1: 1243 – 1244, 1971.
Brown CB, Turner D, Ogg CS, Wilson D, Cameron JS, Chantler C, Gill D: Combined immunosuppression and anti-coagulation in rapidly progressive glomerulonephritis. Lancet 2: 1166 – 1171, 1974.
Cameron JS, Gill D, Turner DR, Chantler C, Ogg CS, Vosnides G, Williams DG: Combined immunosuppression and anti-coagulation in rapidly progressive glomerulonephritis. Lancet 2: 923 – 925, 1975.
McKenzie PE, Taylor AE, Woodroffe AJ, Seymour AE, Chan YL, Clarkson AR: Plasmapheresis in glomerulonephritis. Clin Nephrol 12: 97 – 108, 1979.
Ito K, Narumi F, Ono M, Kawaguchi H: The evaluation of clinical effect of plasma exchange therapy on purpura nephritis in childhood (abstract). Int Congr Nephrol 8: 259, 1981.
Baliah TD, Kim KH, Antigone S, Anthone R, Montes M, Andres GA: Recurrence of Henoch-Schönlein purpura glomerulonephritis in transplanted kidneys. Transplantation 18: 343 – 346, 1974.
Beale MG, Nash GS, Bertovich MJ, MacDermott RP: Similar disturbances in B cell activity and regulatory T cell function in Henoch-Schönlein purpura and systemic lupus erythematosus. J Immunol 128: 486–491, 1982.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishers, Boston / The Hague / Dordrecht / Lancaster
About this chapter
Cite this chapter
Balow, J.E., Austin, H.A. (1984). Vasculitic Diseases of the Kidney. In: Suki, W.N., Massry, S.G. (eds) Therapy of Renal Diseases and Related Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3807-9_20
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3807-9_20
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3809-3
Online ISBN: 978-1-4613-3807-9
eBook Packages: Springer Book Archive